Terms: = Prostate cancer AND HOXC11, HOX3H, 3227, ENSG00000123388, O43248 AND Treatment
3 results:
1. Prosaposin activates the androgen receptor and potentiates resistance to endocrine treatment in breast cancer.
Ali A; Creevey L; Hao Y; McCartan D; O'Gaora P; Hill A; Young L; McIlroy M
Breast Cancer Res; 2015 Sep; 17(1):123. PubMed ID: 26341737
[TBL] [Abstract] [Full Text] [Related]
2. [Endothelin-1 and receptor A: predictive value for biochemical relapse on patients with advanced and metastatic prostate cancer].
Rotondo S; Menard J; Durlach A; Birembaut P; Staerman F
Prog Urol; 2012 Jan; 22(1):38-44. PubMed ID: 22196004
[TBL] [Abstract] [Full Text] [Related]
3. Response of rat and human prostatic cancers to the novel 5 alpha-reductase inhibitor, SK&F 105657.
Lamb JC; Levy MA; Johnson RK; Isaacs JT
Prostate; 1992; 21(1):15-34. PubMed ID: 1641369
[TBL] [Abstract] [Full Text] [Related]
